XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,929 | +7.0% | 5,882 | +20.6% | 0.00% | – |
| Q2 2023 | $187,842 | +13.8% | 4,879 | +5.7% | 0.00% | – |
| Q1 2023 | $165,135 | -10.2% | 4,614 | -1.0% | 0.00% | – |
| Q4 2022 | $183,822 | +49.4% | 4,662 | +36.1% | 0.00% | – |
| Q3 2022 | $123,000 | +61.8% | 3,426 | +38.6% | 0.00% | – |
| Q2 2022 | $76,000 | +100.0% | 2,472 | +102.1% | 0.00% | – |
| Q1 2022 | $38,000 | -32.1% | 1,223 | -31.2% | 0.00% | – |
| Q4 2021 | $56,000 | +250.0% | 1,777 | +73.9% | 0.00% | – |
| Q3 2021 | $16,000 | -15.8% | 1,022 | +0.1% | 0.00% | – |
| Q2 2021 | $19,000 | +5.6% | 1,021 | +2.1% | 0.00% | – |
| Q1 2021 | $18,000 | -33.3% | 1,000 | -41.9% | 0.00% | – |
| Q4 2020 | $27,000 | +22.7% | 1,722 | -13.3% | 0.00% | – |
| Q3 2020 | $22,000 | -24.1% | 1,986 | -12.7% | 0.00% | – |
| Q2 2020 | $29,000 | +314.3% | 2,274 | +259.8% | 0.00% | – |
| Q1 2020 | $7,000 | -69.6% | 632 | -63.9% | 0.00% | – |
| Q4 2019 | $23,000 | +109.1% | 1,753 | +42.4% | 0.00% | – |
| Q3 2019 | $11,000 | -78.4% | 1,231 | -76.0% | 0.00% | – |
| Q2 2019 | $51,000 | +70.0% | 5,123 | +70.8% | 0.00% | – |
| Q1 2019 | $30,000 | +2900.0% | 3,000 | +1913.4% | 0.00% | – |
| Q4 2018 | $1,000 | -90.9% | 149 | -82.6% | 0.00% | – |
| Q3 2018 | $11,000 | +37.5% | 854 | -3.9% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 889 | -64.9% | 0.00% | – |
| Q2 2017 | $8,000 | +60.0% | 2,530 | +310.0% | 0.00% | – |
| Q3 2016 | $5,000 | -37.5% | 617 | -44.2% | 0.00% | – |
| Q1 2016 | $8,000 | -61.9% | 1,106 | -57.9% | 0.00% | – |
| Q4 2015 | $21,000 | +75.0% | 2,629 | +148.5% | 0.00% | – |
| Q2 2015 | $12,000 | +100.0% | 1,058 | +205.8% | 0.00% | – |
| Q1 2015 | $6,000 | -14.3% | 346 | -7.0% | 0.00% | – |
| Q4 2014 | $7,000 | – | 372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |